Neuromuscular blockade is an essential component of modern anaesthetic practice, enabling muscle relaxation during surgery and facilitating procedures such as tracheal intubation and minimally ...

A recent editorial analysis found that neuromuscular blocking agents (NMBAs) significantly increase expiratory tidal volumes ...

Lupin Ltd has obtained tentative approval from the US FDA for its generic version of Sugammadex injection. This drug is used ...

September 16, 2010 — Neuromuscular blockade may improve outcomes in severe acute respiratory distress syndrome (ARDS) without increasing muscle weakness, according to the results of a multicenter, ...

Lupin has received tentative approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for ...

The decision to treat a patient in the intensive care unit (ICU) with neuromuscular blocking agents (NMBAs) (for reasons other than the placement of an endotracheal tube) is a difficult one that is ...

Generic Bridion injection is used for the reversal of neuromuscular blockade induced by rocuronium bromide and vecuronium bromide.

Sugammadex effectively reverses neuromuscular blockade in myasthenia gravis patients, ensuring rapid recovery and minimal complications. The review of 24 studies with 1679 patients showed no ...

Nearly half of drug-caused deaths by health care workers involved drugs that were obtained from their place of work, new research finds. Patients receiving neuromuscular blocking medications as part ...

Lupin secures USFDA tentative approval for Sugammadex injection, a generic alternative for Merck’s Bridion, aiding ...